FIELD: medicine, dermatology, diagnostics. SUBSTANCE: by studying catalase activity in patient's blood serum followed by analysis of the data obtained within a norm it is necessary to predict disease remission from 2 to 6 months, in case of increased values by 2 or more times against a norm remission period within 7-18 months is predicted. EFFECT: higher efficiency and simplification of prediction. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PROGNOSTICATION OF TENDENCY OF PSORIASIS | 1991 |
|
RU2009509C1 |
| METHOD FOR TREATING CHLAMYDIAE-INDUCED INFECTION OF UROGENICAL TRACT IN WOMEN | 1994 |
|
RU2108104C1 |
| METHOD FOR TREATING BACTERIAL CHLAMYDIA PROSTATITIS | 1994 |
|
RU2108818C1 |
| METHOD OF PSORIASIS TREATMENT | 1992 |
|
RU2061483C1 |
| METHOD FOR PROGNOSTICATING PROGRESS OF PSORIATIC ARTHRITIS | 1991 |
|
RU2032379C1 |
| METHOD FOR PREDICTING ACANTHOLYTIC PEMPHIGUS RECURRENCE | 2001 |
|
RU2199127C1 |
| METHOD FOR TREATING THE CASES OF FOCAL ALOPECIA IN CHILDREN | 1998 |
|
RU2159638C2 |
| METHOD OF PSORIASIS TREATMENT | 0 |
|
SU1805986A3 |
| METHOD FOR DETECTING TREATMENT-RESISTANT PATIENTS WITH CHRONIC ADVANCED DERMATOSES (PSORIASIS, ATOPIC DERMATITIS, ACANTHOLYTIC VESICULAR DERMATITIS) | 2011 |
|
RU2457489C1 |
| METHOD OF PROGNOSIS OF PSORIASIS COURSE | 1997 |
|
RU2134882C1 |
